publication date: Dec. 19, 2010

In this issue: 

FDA, NCI united in pursuit of 2015 goal, Andrew von Eschenbach tells cancer center directors; says his appointment was necessary to “maintain the momentum of the FDA.”

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

NIH establishes new clinical science awards to eventually replace General Clinical Research Centers.

Download (PDF 474KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.